Sigma Labs Announces Proposed Underwritten Public Offering of Common Stock
July 30 2019 - 4:15PM
Sigma Labs, Inc. (NASDAQ: SGLB) (“Sigma Labs”), a provider of
quality assurance software, today announced that it intends to
offer shares of its common stock for sale in an underwritten public
offering. In addition, the Company expects to grant the
underwriters a 45-day option to purchase up to an additional 15
percent of the shares of common stock offered in the public
offering solely to cover over-allotments, if any. The Company
intends to use the net proceeds from this offering for operations,
including for the development and marketing of its products and
services, and payment of general and administrative expenses and
other working capital and general corporate purposes, which may
include the repayment of debt and other capital expenditures. The
offering is subject to market conditions and there can be no
assurance as to whether or when the offering may be completed, or
as to the actual size or terms of the offering.
Aegis Capital Corp. is acting as the sole book-runner for
the proposed offering.
The offering is being made pursuant to an effective shelf
registration statement on Form S-3 (No. 333-225377) previously
filed with the U.S. Securities and Exchange Commission (the “SEC”)
and declared effective by the SEC on June 14, 2018. A final
prospectus supplement and accompanying prospectus describing the
terms of the proposed offering will be filed with the SEC and
available on the SEC’s website located at http://www.sec.gov.
Electronic copies of the final prospectus supplement and the
accompanying prospectus, when available, may be obtained by
contacting Aegis Capital Corp., Attention: Prospectus Department,
810 7th Avenue, 18th floor, New York, NY 10019, by email at
prospectus@aegiscap.com, or by telephone at (212) 813-1010. Before
investing in this offering, interested parties should read in their
entirety the prospectus supplement and the accompanying prospectus
and the other documents that the Company has filed with the SEC
that are incorporated by reference in such prospectus supplement
and the accompanying prospectus, which provide more information
about the Company and such offering.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
About Sigma Labs
Sigma Labs, Inc. is a provider of quality assurance software
under the PrintRite3D® brand and a developer of advanced,
in-process, non-destructive quality assurance software for
commercial firms worldwide seeking productive solutions for
advanced manufacturing. For more information, please visit us at
www.sigmalabsinc.com.
Forward-Looking Statements This press release
contains “forward-looking statements” within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended (which Sections
were adopted as part of the Private Securities Litigation Reform
Act of 1995). Statements preceded by, followed by or that otherwise
include the words “believe,” “anticipate,” “estimate,” “expect,”
“intend,” “plan,” “project,” “prospects,” “outlook,” and similar
words or expressions, or future or conditional verbs such as
“will,” “should,” “would,” “may,” and “could” are generally
forward-looking in nature and not historical facts. These
forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause the Company's
actual results, performance or achievements to be materially
different from any anticipated results, performance or
achievements. The Company disclaims any intention to, and
undertakes no obligation to, revise any forward-looking statements,
whether as a result of new information, a future event, or
otherwise. For additional risks and uncertainties that could impact
the Company’s forward-looking statements, please see the Company’s
Annual Report on Form 10-K (including but not limited to the
discussion under “Risk Factors” therein) filed with the SEC on
April 1, 2019 and which may be viewed at
http://www.sec.gov.Contacts:Media
Relations: DGI Comm 212-825-3210Investor
Relations: Bret Shapiro Managing Director CORE IR
561-479-8566 brets@coreir.com
News Provided by GlobeNewswire via QuoteMedia
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Sep 2023 to Sep 2024